ScholarIQanswers from OpenAlex

Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis

PaperCitations, authors & open-access status

Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis have?

ScholarIQcitation count

Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis has 137 citations in the OpenAlex counts ScholarIQ stores.

When was Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis published?

ScholarIQyear

Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis has 2011 year in the ScholarIQ index.

What is the open-access status of Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis?

ScholarIQoa status

Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis has green oa status in the ScholarIQ index.

What is the DOI of Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis?

ScholarIQdoi

The DOI for Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis is on the source record.

What is the PMID of Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis?

ScholarIQpmid

The PMID for Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis is on the source record.

What is the OpenAlex record for Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis?

ScholarIQopenalex

The OpenAlex for Randomised, double-blind, placebo-controlled study of tacrolimus in myasthenia gravis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial